HON — Honeywell International Inc.

The tape is unambiguously negative as of 2026-09-13: -14.0% over one month, -17.7% over six months, -12.4% over three months, with the shares at $202.36 versus a 52-week range of $195.87-$260.28 and RSI(14) at 29.1 - a stock pinned near its lows with all three moving averages overhead. The narrative driving it: HON just shed Aerospace, its highest-quality and highest-margin segment, and the market is now valuing an unproven ~$20B standalone automation stub guiding to only 2-3% organic growth, while headlines about HONA supplier bottlenecks and slow manufacturing qualification bleed into sector sentiment. The divergence worth noting is sell-side: 20 Buy / 10 Hold / 0 Sell with a $261.82 consensus target (12 analysts, range $239-$293) implies +29% upside, but those targets read as stale or sum-of-the-parts-based and have not been marked to the standalone entity post-split, so they are not a credible counterweight to the price action.

Split the series into pre- and post-spin, because the June 29, 2026 separation breaks comparability. Pre-spin, growth was steady and modest: Q3'23 $9,212M -> Q3'24 $9,728M -> Q3'25 $10,408M on revenue, with operating income of $1,926M / $1,983M / $1,754M respectively. Post-spin, the reported declines are artifacts, not deterioration: Q4'25 revenue of $6,860M vs. $10,088M in Q4'24, Q1'26 $9,143M vs. $9,822M, and Q2'26 $9,719M vs. $10,352M (-6.1% YoY) - all of which reflect the removal of Aerospace, not organic decline. Management reported Q2 2026 as +4% organic sales growth with segment margin expanding 30bp to 23.1%, and Q2'26 operating margin printed 17.9% versus 16.9% in Q3'25 on like-for-like reported figures. Earnings per share are unusable for trend work: Q2'26 diluted EPS of $17.81 and net income of $5,682M are inflated by the one-time separation gain, while Q4'25 showed a net loss of -$115M (EPS -$0.36). The cleanest read is gross margin, which has held in a 36-39% band for three years ($3,539M on $9,143M = 38.7% in Q1'26; $3,653M on $9,719M = 37.6% in Q2'26). Verdict: stable-to-slightly-improving operating quality on a like-for-like basis, wrapped inside reported numbers that look like a collapse - with the caveat that Q1'26 operating cash flow was -$650M, a genuine flag worth watching for separation costs and working-capital drag.

As of 2026-09-13, HON is fairly valued, not cheap. The headline 7.85x P/E, 0.172 PEG and 1.78x P/S scream bargain, and the deterministic screen labels it 'Cheap vs. its own history' (P/E 7.85 vs. 5yr avg 13.21; P/S 1.775 vs. 5yr avg 2.00) - all of that is an illusion. TTM EPS of $25.89 contains the $5.68B non-cash separation gain, so the real earnings base is FY26 guidance of $7.90-$8.30 (midpoint $8.10, ~25.0x) and FY27 consensus of $8.325 (~24.3x). TTM revenue of $36,130M still includes divested Aerospace, so the true standalone P/S on guided revenue of $19.9-$20.2B is ~3.2x - higher, not lower, than the 2.00x five-year average. Against automation peers (ROK, EMR, ABB in the ~22-26x forward range) and against HON's own historical forward multiple, ~24-25x for 2-3% organic growth is full, not discounted. ROIC of 9.2% against a 30.6% ROE tells you the equity returns are buyback-flattered, not capital-efficiency-driven.

The entire tension is price versus estimates. At $202.36 the market is paying ~24.3x FY27 consensus EPS of $8.325 against expected EPS growth of roughly +2.8% off the FY26 midpoint of $8.10 - i.e., a low-growth industrial at a full-sector multiple. The sell-side $261.82 target implies ~31x FY26 EPS and only works if you underwrite mid-single-digit organic growth returning and segment margins climbing from 23.1% toward the mid-20s - a 2028-2029 story, not a next-four-quarters story. So don't buy the 7.9x 'cheap P/E' screen: it does not exist. Equally, don't short the 31x sell-side target as if it's priced in: at 24x with the stock already down 17.7% over six months, most of the optimism has been marked out. The realistic near-term outcome distribution is dead money (multiple holds 22-25x, EPS grows 3%) versus upside requiring Q3/Q4 proof of standalone margin expansion and cash conversion.

As of 2026-09-13 the technical picture is a confirmed downtrend with a stretched oversold reading: RSI(14) 29.11, price 5.89% below the SMA20 (~$215), 10.83% below the SMA50 (~$227), and 11.96% below the SMA200 (~$230) - all three averages stacked overhead, which is the textbook signature of a sustained decline rather than a range. Returns as of that date were -3.46% (1 week), -14.01% (1 month), -12.42% (3 months) and -17.72% (6 months), with the shares at $202.36 versus the 52-week low of $195.87. Implication for entry timing: RSI near 30 with price pinned at a 52-week low often produces a reflexive bounce, and the September 15 Morgan Stanley presentation is a plausible trigger - but there is no trend confirmation until price reclaims the SMA50 (~$227). Buying here is a tactical oversold trade with no margin of safety, not a fundamental entry; staged accumulation or waiting for a higher low is the more disciplined approach.

• Industrial capex discipline and factory-automation demand: the secular tailwind (reshoring, labor scarcity, AI/industrial software layers such as Honeywell Forge) is real, but capital-intensive customers remain cautious around shifting rate expectations - the sobering evidence is management's own 2-3% organic growth guide for FY26.
• Interest rates: HON carries ~$26.2B of long-term debt against $8.75B of cash (net debt ~$17.5B at 6/30/26); lower rates ease refinancing costs and support long-duration industrial multiples, while higher-for-longer pressures both the earnings math and the multiple.
• Post-spin index and flow dynamics: the June 29, 2026 separation forced index rebalancing, add/delete decisions and portfolio reallocation across HON and HONA, generating technical selling in the retained entity that has little to do with automation fundamentals - a real but fading headwind.
• Aerospace supply chain bottlenecks: HONA's supplier and manufacturing-qualification problems are no longer HON's problem financially, but they degrade sector sentiment on the legacy name and serve as a reminder that the retained automation business also depends on qualified vendors for long-cycle project delivery.
• Tariffs and trade policy: targeted Canadian steel and lumber tariffs have had limited direct effect given the pivot away from cyclical materials toward high-value automation, but a broader escalation would hit industrial capex budgets and project timing.

• Morgan Stanley Laguna Conference, September 15, 2026 - CEO Vimal Kapur and CFO Mike Stepniak present. Any upgrade to standalone margin targets, cost-out quantification, or a buyback framework is the first genuine post-spin re-rating trigger.
• Q3 2026 earnings (expected late October 2026): the second quarter as a pure-play. Watch whether the +4% organic growth and 30bp segment-margin expansion repeat, and whether cash flow normalizes after the -$650M operating cash flow in Q1'26.
• Pure-play automation re-rating as the market shifts from valuing HON as a diluted conglomerate to benchmarking it against ROK, EMR and ABB - plus potential portfolio M&A or accelerated capital return using the standalone balance sheet.
• Honeywell Forge / AI-software monetization and automation order book acceleration - the single most credible support for holding a ~25x forward multiple on 2-3% organic growth.
• HONA stabilization: if Aerospace supplier bottlenecks clear, headline sector sentiment improves, though HON shareholders no longer own that asset.

• The 'cheap' thesis evaporates on inspection: once the market fully normalizes to a ~24-25x multiple on $8.1-8.3 of EPS, HON is a fairly-to-fully valued 2-3% organic grower, leaving limited multiple cushion if growth or margins disappoint.
• Transition execution risk: a ~$20B standalone entity with one quarter of clean reporting, a -$650M operating cash flow quarter in Q1'26, and standalone corporate costs still being sized.
• Balance sheet: ~$17.5B net debt against roughly $2.5B of FY26E net income (~3x net debt/EBITDA) with total debt-to-equity of 1.35 - limited room to fund a large buyback and strategic M&A simultaneously without adding leverage.
• Low capital efficiency: ROIC of 9.2% versus a 30.6% ROE that is flattered by a buyback-thinned equity base; the retained automation business is structurally less capital-efficient than the Aerospace unit just spun off.
• Cycle timing risk: if industrial automation demand rolls over with industrial production, a 2-3% organic guide can turn negative quickly, and the company has minimal standalone track record to demonstrate resiliency.
• Stale sell-side expectations: a $261.82 consensus target ~29% above the price creates asymmetric disappointment risk if Q3 guidance is merely in line.

Not a buy at $202.36 for a fundamentals-driven investor. The two things that make HON screen cheap - a 7.85x P/E and a below-history P/S - are both artifacts of the June 29, 2026 Aerospace spin-off and the one-time $5.68B separation gain; corrected, the stock trades ~24-25x FY26/FY27 EPS of ~$8.1/$8.3 against 2-3% organic growth, 9.2% ROIC and ~$17.5B of net debt. That is a fair price for a decent pure-play automation business with about a third of revenue in recurring aftermarket service and a real secular tailwind - meaningfully better than the 'Weak Fundamentals' score implies, but offering no margin of safety and no reason to chase a falling knife with RSI at 29 and every moving average overhead. Either wait for the Q3 print to confirm mid-20s segment margins and normalizing cash conversion, or wait for a price that actually discounts the low-growth reality (roughly the high-$170s to low-$180s).

Blended forward-multiple approach as of 2026-09-13: primary leg applies 24.5x to FY2027 consensus EPS of $8.325, yielding ~$204/share; cross-check leg applies 18x EV/EBITDA to ~$4.6B of FY26E standalone EBITDA ($82.8B EV, less ~$17.5B net debt, divided by 317M post-split shares), yielding ~$206/share; 60/40 weighted gives $205. The multiple is a modest premium to HON's historical forward range, justified by ~one-third recurring aftermarket revenue, a 0.90 beta and 23.1% segment margins still expanding, but capped by 2-3% organic growth and 9.2% ROIC - and it sits well below the ~31x implied by the $261.82 sell-side consensus, which I treat as stale post-spin.